News Agency
The Times Real Estate

Gracell Biotechnologies Doses First Patient in Phase 2 Portion of Registrational Phase 1/2 Clinical Trial Evaluating GC007g for Treatment of B-cell Acute Lymphoblastic Leukemia

  • Written by PR Newswire
Gracell Biotechnologies Doses First Patient in Phase 2 Portion of Registrational Phase 1/2 Clinical Trial Evaluating GC007g for Treatment of B-cell Acute Lymphoblastic Leukemia

Clinical trial assessing allogeneic, HLA-matched, donor-derived allogeneic CAR-T therapy

SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, Oct. 17, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious...

Read more: Gracell Biotechnologies Doses First Patient in Phase 2 Portion of Registrational Phase 1/2...

How to Send Money to the Pacific Islands: Step-by-Step Guide

Remitting money to the Pacific Islands can be very helpful to our families, friends and other business people there. Whether you are wiring money to Fiji, Samoa, Tonga, or any other island nation, it is crucial to get insight into... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion